Cubist Systematic Strategies, LLC Gilead Sciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 7,100 shares of GILD stock, worth $648,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,100

Previous 241,686 97.06%

Holding current value

$648,585

Previous $16.6 Million 96.41%

% of portfolio

0.0%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $555,783 - $641,416	-8,801 Reduced 3.51%	241,686 $16.6 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $12.8 Million - $15.7 Million	179,417 Added 252.45%	250,487 $18.3 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $4.52 Million - $5.13 Million	61,722 Added 660.27%	71,070 $5.76 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $691,191 - $754,103	9,348 New	9,348 $700,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $20.2 Million - $23.1 Million	-261,714 Reduced 54.24%	220,831 $18.3 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $3.7 Million - $5.31 Million	-59,335 Reduced 10.95%	482,545 $41.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $15.8 Million - $18.1 Million	265,585 Added 96.12%	541,880 $33.4 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $11.4 Million - $12.9 Million	-197,953 Reduced 41.74%	276,295 $17.1 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $20.2 Million - $25.4 Million	349,488 Added 280.13%	474,248 $28.2 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $3.12 Million - $3.55 Million	48,154 Added 62.86%	124,760 $9.06 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $3.74 Million - $4.04 Million	-55,320 Reduced 41.93%	76,606 $5.35 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $223,414 - $244,111	3,520 Added 2.74%	131,926 $9.08 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $393,120 - $448,549	6,552 Added 5.38%	128,406 $8.3 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.31 Million - $2.64 Million	40,856 Added 50.44%	121,854 $7.1 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $3.95 Million - $4.96 Million	63,588 Added 365.24%	80,998 $5.12 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $2.03 Million - $2.36 Million	-28,056 Reduced 61.71%	17,410 $1.34 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $2.62 Million - $3.35 Million	-41,816 Reduced 47.91%	45,466 $3.4 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $7.29 Million - $8.02 Million	-118,383 Reduced 57.56%	87,282 $5.67 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.21 Million - $2.44 Million	-35,292 Reduced 14.65%	205,665 $13 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $11.3 Million - $12.7 Million	182,921 Added 315.19%	240,957 $16.3 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $4.91 Million - $5.5 Million	-78,500 Reduced 57.49%	58,036 $3.77 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $7.54 Million - $9.85 Million	124,627 Added 1046.49%	136,536 $8.54 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $332,164 - $367,767	-4,660 Reduced 28.12%	11,909 $919,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $41,912 - $48,889	-646 Reduced 3.75%	16,569 $1.17 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $643,759 - $784,814	8,838 Added 105.5%	17,215 $1.3 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.04 Million - $1.22 Million	-14,589 Reduced 63.52%	8,377 $600,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.66 Million - $1.96 Million	22,966	22,966 $1.86 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Gilead Sciences, Inc. Transaction History